Extracted from this filing and checked against the source text.
Material AgreementsSEC 8-K Item 1.01/1.02confidence 0.9
BiomX Inc. entered into SPA valued at approximately $1.5 million (effective 2023-02-22).
Action
entry
Agreement
equity purchase
Value
approximately $1.5 million
Effective
2023-02-22
Exact text from the filing
On February 22, 2023, BiomX Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ SPA ”) relating to a private placement (the “ Offering ”) of an aggregate of 30,608,164 shares of the Company’s common stock (“ Shares ”), including shares issuable upon the exercise of pre-funded warrants (“ Pre-Funded Warrants ”) to purchase additional shares of the Company’s common stock (each, a “ Security ” and collectively, the “ Securities ”), at a purchase price of $0.245 per Share and $0.244 per Pre-Funded Warrant. On February 27, 2023, the Company completed the first closing of the Offering and issued an aggregate of 5,975,919 Securities for gross proceeds of approximately $1.5 million.
Material AgreementsSEC 8-K Item 1.01/1.02confidence 0.9
BiomX Inc. entered into Registration Rights Agreement with the investors participating in the Offering (effective 2023-02-27).
Action
entry
Counterparty
the investors participating in the Offering
Effective
2023-02-27
Exact text from the filing
As a condition to the closing, on February 27, 2023, the Company entered into a Registration Rights Agreement with the investors participating in the Offering.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.